發布時間:2023-04-28所屬分類:國際sci|ssci瀏覽:1次
重癥醫學領域sci期刊眾多,作者在選擇sci期刊之前,一定要確保文章方向和水平符合目標sci期刊要求,綜合考量后,將文章發表sci期刊。下面是對重癥醫學領域sci論文國內案例介紹,希望能夠幫助到大家。
1、《Journal of Thoracic Disease》雜志發表了題為“Efficacy and safety of colistin sulfate in the treatment of infections caused by carbapenem-resistant organisms: a multicenter retrospective cohort study”文章,作者來自中國河南省人民醫院研究者。
2、《Critical Care Medicine》雜志上發表的Twenty-one patients with severe acute respiratory distress syndrome (ARDS) in COVID-19 who received extracorporeal membrane oxygenation (ECMO) were studied. It was found that ECMO was an effective treatment for this disease, and the opportunity to start ECMO was found. 文章,作者來自中國武漢大學中南醫院ECMO團隊。
3、《Lancet Respiratory Medicine》雜志發表的《Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis》文章,作者為來自中國的研究者。
4、《Intensive Care Medicine》雜志發表的《Early awake prone position combined with high-flow nasal oxygen therapy in severe COVID-19: a case series》文章,作者為來自中國的研究者。
5、《Critical Care Medicine》雜志發表的《Positive end-expiratory pressure titration in COVID-19 acute respiratory distress syndrome: electrical impedance tomography vs. PEEP/FiO2 tables》文章,作者為來自中國的研究者。
這些重癥醫學領域sci論文國內案例,展示了中國在重癥醫學領域的研究和成果,為世界范圍內的疾病防治做出了貢獻。如果對文章發表sci期刊有疑問,可找學術顧問指導。
* 請認真填寫需求信息,我們會在24小時內與您取得聯系。